| Literature DB >> 35814687 |
Haiping Gu1, Shikai Zhang1, Lin Liu1, Zhengyou Yang1, Fengchun Zhao1, Yuan Tian2.
Abstract
Endophytic fungi of medicinal plants are important sources of active natural products. In this study, 26 fungi were isolated from Artemisia argyi, which were belonging to eight genera, namely, Alternaria, Fusarium, Chaetomium, Phoma, Diaporthe, Trichoderma, Gibberella, and Colletotrichum. The antimicrobial activities of all fungal extracts were tested by using the cup-plate method against Staphylococcus aureus, Salmonella enteritidis, and Fusarium graminearum. The results demonstrated that 25 extracts (96%) exhibited inhibitory activity against at least one of the tested pathogenic microorganisms. The strain Diaporthe sp. AC1, which showed good antimicrobial activity and high yield of crude extract from fermentation, was selected for the study of secondary metabolites. The crude extract of strain AC1 was purified by silica gel column chromatography, Sephadex LH-20 gel column chromatography, and HPLC, and finally, a new compound phomopsolide G (1), together with three known phomopsolides (2-4) and four other known compounds (5-8), was obtained. The structures of the compounds were elucidated by NMR and/or HR-MS spectroscopy. Microdilution method and MTT colorimetry were used to determine the bioactivity of the compounds. The study demonstrated that the new compound 1 had moderate antifungal activity against F. graminearum, Fusarium moniliforme, and Botrytis cinerea and weak antibacterial activity against Staphylococcus aureus. Compound 1 also showed weak cytotoxicity against HepG2, A549, and MDA-MB-231, with IC50 values of 89.91, 107.65, and 53.97 μM. Additionally, other compounds also exhibited antimicrobial and/or cytotoxic activities. The findings provided the basis for searching drug and agricultural lead compounds from A. argyi-associated fungi resources.Entities:
Keywords: Artemisia argyi; antimicrobial activity; cytotoxic activity; endophytic fungi; secondary metabolites
Year: 2022 PMID: 35814687 PMCID: PMC9260665 DOI: 10.3389/fmicb.2022.908836
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
FIGURE 1Work up schema of the endophytic fungus strain AC1.
The separation tissues and homologous strains of endophytic fungi from A. argyi.
| Strains | Plant tissue | Closest sequences by BlastN | Coverage/max ident | Accession | Genbank |
| AC1 | Root |
| 99/99.44 |
| OL589639 |
| AC2 | Root |
| 99/100.00 |
| OM763739 |
| AC3 | Stem | 98/96.67 |
| OM763740 | |
| AC4 | Stem |
| 100/99.81 |
| OM763741 |
| AC5 | Stem |
| 100/99.81 |
| OM763742 |
| AC6 | Stem | 99/99.60 |
| OM763743 | |
| AC7 | Stem |
| 98/100.00 |
| OM763744 |
| AC8 | Stem |
| 100/99.62 |
| OM763745 |
| AC9 | Stem | 98/99.8 |
| OM763746 | |
| AC10 | Stem | 100/100.00 |
| OM763747 | |
| AC11 | Stem |
| 100/100.00 |
| OM763748 |
| AC12 | Stem |
| 97/99.62 |
| OM763749 |
| AC13 | Leaf |
| 97/99.43 |
| OM763750 |
| AC14 | Leaf |
| 96/99.44 |
| OM763751 |
| AC15 | Leaf |
| 99/99.81 |
| OM763752 |
| AC16 | Leaf |
| 100/99.44 |
| OM763753 |
| AC17 | Leaf |
| 100/99.81 |
| OM763754 |
| AC18 | Leaf |
| 97/99.62 |
| OM763755 |
| AC19 | Leaf | 94/99.22 |
| OM763756 | |
| AC20 | Leaf |
| 98/100 |
| OM763757 |
| AC21 | Leaf |
| 99/99.26 |
| OM763758 |
| AC22 | Leaf |
| 99/100 |
| OM763759 |
| AC23 | Leaf |
| 100/99.81 |
| OM763760 |
| AC24 | Leaf |
| 99/99.41 |
| OM763761 |
| AC25 | Leaf |
| 98/99.81 |
| OM763762 |
| AC26 | Leaf |
| 99/99.60 |
| OM763763 |
FIGURE 2Neighbor-joining phylogenetic tree based on ITS sequences of 26 endophytic strains. Numbers at the branch points are the bootstrap values based on 1,000 resamplings. The scale bar represents 0.01 nucleotide changes per position.
Yields and antimicrobial activities of the crude extracts from endophytic fungi.
| Strain | Total weight of extract (mg/L) | Inhibitory zone diameter/mm | ||
|
| ||||
|
|
|
| ||
| AC1 | 474 | 13.8 | 21.8 | 12.5 |
| AC2 | 188 | 11.5 | 19.7 | − |
| AC3 | 211 | − | 13.3 | A |
| AC4 | 311 | 12.3 | 13.3 | 14.5 |
| AC5 | 371 | 13.0 | 19.8 | 19.0 |
| AC6 | 143 | 12.3 | 20.3 | 12.5 |
| AC7 | 1,180 | 13.3 | 19.3 | − |
| AC8 | 171 | 14.0 | 18.7 | 11.8 |
| AC9 | 57 | − | 12.3 | − |
| AC10 | 354 | 12.8 | 22.3 | 19.0 |
| AC11 | 298 | 13.3 | 14.3 | 16.0 |
| AC12 | 357 | − | − | a |
| AC13 | 379 | 14.0 | 15.3 | a |
| AC14 | 580 | − | 20.5 | 15.5 |
| AC15 | 31 | 12.8 | − | a |
| AC16 | 314 | 15.3 | 21.3 | 13.3 |
| AC17 | 186 | 13.8 | 19.5 | a |
| AC18 | 201 | 13.7 | 14.8 | a |
| AC19 | 209 | 12.3 | 15.8 | − |
| AC20 | 187 | 12.8 | − | − |
| AC21 | 169 | 13.0 | − | − |
| AC22 | 57 | 12.5 | 18.5 | − |
| AC23 | 176 | − | − | a |
| AC24 | 378 | − | − | 16.0 |
| AC25 | 236 | − | − | 18.0 |
| AC26 | 361 | − | − | − |
| Ampicillin sodium | 36.7 | 40.0 | n | |
| Actinomycin | n | n | 27.5 | |
“−” means no inhibition. “a” means there was inhibitory effect, but the boundary of the inhibition zone was not clear. “n” means not tested.
FIGURE 3Antifungal activity of the crude extract from strain AC1. (A) F. graminearum; (B) F. moniliforme; (C) B. cinerea; (D) V. dahlia (left: control group; right: experimental group).
13C-NMR and 1H-NMR data of compounds 1 and 2.
| δ | δ | |||
|
|
| |||
| No. | 1 | 2 | 1 | 2 |
| 1 | 161.92 | 162.00 | ||
| 2 | 124.74 | 124.75 | 6.22 (d, 9.6 Hz, 1 H) | 6.25 (d, 9.7 Hz, 1 H) |
| 3 | 141.26 | 140.52 | 7.16 (dd, 9.6, 5.9 Hz, 1 H) | 7.04 (dd, 9.7, 5.8 Hz, 1 H) |
| 4 | 60.87 | 67.03 | 5.42 (dd, 6.0, 2.5 Hz, 1 H) | 5.45 (dd, 5.9, 2.7 Hz, 1 H) |
| 5 | 79.27 | 80.43 | 4.45 (dd, 9.1, 2.5 Hz, 1 H) | 4.58 (dd, 6.8, 2.7 Hz, 1 H) |
| 6 | 74.32 | 61.59 | 4.18 (m, 1 H) | 4.26 (q, 7.1 Hz, 1 H) |
| 7 | 39.32 | 39.29 | 3.05 (dd, 16.9, 4.1 Hz, 1 H) | 2.81 (dd, 16.1, 3.8 Hz, 1 H) |
| 8 | 210.41 | 211.00 | ||
| 9 | 73.16 | 73.68 | 4.37 (q, 7.2 Hz, 1 H) | 4.56–4.48 (m, 1 H) |
| 10 | 19.35 | 19.18 | 1.43 (d, 7.12 Hz, 3 H) | 1.38 (d,7.1 Hz, 3 H) |
|
|
| |||
| 1′ | 166.47 | 166.57 | ||
| 2′ | 127.54 | 127.36 | ||
| 3′ | 139.96 | 140.43 | 6.98–6.92 (m, 1 H) | 6.96–6.81 (m, 1 H) |
| 4′ | 12.09 | 12.06 | 1.86–1.79 (m, 6 H) | 1.86–1.79 (m, 6 H) |
| 5′ | 14.67 | 14.69 | ||
Bold values can make it easier for the reader to see the difference between the two compounds.
FIGURE 4Key HMBC (blue arrow) and 1H–1H COSY correlations (black bond) of 1.
FIGURE 5Structures of compounds 1–8.
Antifungal activity of compounds 1–8 and cycloheximide.
| Compounds | Pathogenic fungi (MIC μg/ml) | |||
|
| ||||
|
|
|
|
| |
|
| 256 | 512 | 256 | − |
|
| − | − | − | − |
|
| 512 | − | − | − |
|
| 256 | 256 | 512 | 512 |
|
| 128 | 256 | 128 | 512 |
|
| − | − | − | − |
|
| 512 | 256 | 512 | 256 |
|
| − | − | − | − |
| Actinomycin | 64 | 128 | 128 | 128 |
“−” means no inhibition.
Antibacterial activity of compounds 1–8 and ampicillin sodium.
| Compounds | Pathogenic bacteria (MIC μg/ml) | |||
|
| ||||
|
|
|
|
| |
|
| 256 | − | b | − |
|
| 512 | − | b | − |
|
| 64 | b | b | 512 |
|
| 64 | 512 | 512 | 256 |
|
| 256 | 256 | 512 | 256 |
|
| 512 | − | − | − |
|
| 256 | − | − | 256 |
|
| − | − | − | − |
| Ampicillin sodium | 2 | 64 | 32 | 128 |
“−” means no inhibition. “b” means there was antibacterial effect but MIC > 512 μg/ml.
FIGURE 6Inhibition rates against three cancer cells of different concentrations of compounds 1–5. (A) HepG2; (B) A549; (C) MDA-MB-231.